The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tau von Hansson, Oskar, Batrla, Richard, Brix, Britta, Carrillo, Maria C., Corradini, Veronika, Edelmayer, Rebecca M., Esquivel, Rianne N., Hall, Christina, Lawson, John, Bastard, Nathalie Le, Molinuevo, José Luis, Nisenbaum, Laura K., Rutz, Sandra, Salamone, Salvatore J., Teunissen, Charlotte E., Traynham, Christopher, Umek, Robert M., Vanderstichele, Hugo, Vandijck, Manu, Wahl, Simone, Weber, Christopher J., Zetterberg, Henrik, Blennow, Kaj

Volltext

Gene Expression and Pharmacodynamic Changes in 1,760 Systemic Lupus Erythematosus Patients From Two Phase III Trials of BAFF Blockade With Tabalumab von Hoffman, Robert W., Merrill, Joan T., Alarcón‐Riquelme, Marta M. E., Petri, Michelle, Dow, Ernst R., Nantz, Eric, Nisenbaum, Laura K., Schroeder, Krista M., Komocsar, Wendy J., Perumal, Narayanan B., Linnik, Matthew D., Airey, David C., Liu, Yushi, Rocha, Guilherme V., Higgs, Richard E.

Volltext

Multiple Regulatory Variants Modulate Expression of 5-Hydroxytryptamine 2A Receptors in Human Cortex von Smith, Ryan M, Papp, Audrey C, Webb, Amy, Ruble, Cara L, Munsie, Leanne M, Nisenbaum, Laura K, Kleinman, Joel E, Lipska, Barbara K, Sadee, Wolfgang

Volltext

A framework for translating tauopathy therapeutics: Drug discovery to clinical trials von Feldman, Howard H., Cummings, Jeffrey L., Boxer, Adam L., Staffaroni, Adam M., Knopman, David S., Sukoff Rizzo, Stacey J., Territo, Paul R., Arnold, Steven E., Ballard, Clive, Beher, Dirk, Boeve, Bradley F., Dacks, Penny A., Diaz, Kristophe, Ewen, Colin, Fiske, Brian, Gonzalez, M. Isabel, Harris, Glenn A., Hoffman, Beth J., Martinez, Terina N., McDade, Eric, Nisenbaum, Laura K., Palma, Jose‐Alberto, Quintana, Melanie, Rabinovici, Gil D., Rohrer, Jonathan D., Rosen, Howard J., Troyer, Matthew D., Kim, Doo Yeon, Tanzi, Rudolph E., Zetterberg, Henrik, Ziogas, Nick K., May, Patrick C., Rommel, Amy

Volltext

CYP2D6 predicted metabolizer status and safety in adult patients with attention-deficit hyperactivity disorder participating in a large placebo-controlled atomoxetine maintenance o... von Fijal, Bonnie A., Guo, Yingying, Li, Si G., Ahl, Jonna, Goto, Taro, Tanaka, Yoko, Nisenbaum, Laura K., Upadhyaya, Himanshu P.

Volltext

Antipsychotic-induced gene regulation in multiple brain regions von Girgenti, Matthew James, Nisenbaum, Laura K, Bymaster, Franklin, Terwilliger, Rosemarie, Duman, Ronald S, Newton, Samuel Sathyanesan

Volltext

The effect of streptozotocin-induced diabetes on cell proliferation in the rat dentate gyrus von Jackson-Guilford, Joy, Leander, J.David, Nisenbaum, Laura K.

Volltext

Serotonin 2A Receptor SNP rs7330461 Association with Treatment Response to Pomaglumetad Methionil in Patients with Schizophrenia von Nisenbaum, Laura K, Downing, AnnCatherine M, Zhao, Fangyi, Millen, Brian A, Munsie, Leanne, Kinon, Bruce J, Adams, David H, Gomez, Juan Carlos, Penny, Michelle Ann

Volltext

Fast Fos: rapid protocols for single- and double-labeling c-Fos immunohistochemistry in fresh frozen brain sections von Sundquist, Sarah J., Nisenbaum, Laura K.

Volltext

Modulation of neurotransmitter release in orexin/hypocretin-2 receptor knockout mice: A microdialysis study von Ortega, Jorge E., Katner, Jason, Davis, Richard, Wade, Mark, Nisenbaum, Laura, Nomikos, George G., Svensson, Kjell A., Perry, Kenneth W.

Volltext

Olanzapine Reversed Brain Gene Expression Changes Induced by Phencyclidine Treatment in Non-Human Primates von Martin, Maureen V., Mirnics, Karoly, Nisenbaum, Laura K., Vawter, Marquis P.

Volltext

Subgroup Analyses of the Amyloid PET Substudies From EMERGE and ENGAGE, Phase 3 Clinical Trials Evaluating Aducanumab in Patients With Early Alzheimer’s Disease (P1-1.Virtual) von Chen, Tianle, Rajagovindan, Rajasimhan, Wu, Hao, Tian, Ying, Nisenbaum, Laura, Castrillo-Viguera, Carmen, He, Ping, Haeberlein, Samantha Budd

Volltext

Group II Metabotropic Glutamate Receptor Modulation of DOI-induced c-fos mRNA and Excitatory Responses in the Cerebral Cortex von Zhai, Yan, George, Carolyn A, Zhai, Jin, Nisenbaum, Eric S, Johnson, Michael P, Nisenbaum, Laura K

Volltext

CSF biomarker concordance with amyloid PET in Phase 3 studies of aducanumab von Nisenbaum, Laura, Martone, Robert, Chen, Tianle, Rajagovindan, Rajasimhan, Dent, Gersham, Beaver, John, Rubel, Carrie, Racine, Annie, He, Ping, Harrison, Katie, Dean, Robert, Vandijck, Manu, Haeberlein, Samantha Budd

Volltext

Reductions in Biomarkers of Alzheimer’s Disease Pathophysiology Following Treatment With Aducanumab Were Associated With Slowing in Clinical Decline (P1-1.Virtual) von Chen, Tianle, Rajagovindan, Rajasimhan, Nisenbaum, Laura, Tian, Ying, Muralidharan, Kumar Kandadi, Dent, Gersham, He, Ping, Castrillo-Viguera, Carmen, Haeberlein, Samantha Budd

Volltext

Phencyclidine-induced changes in rat cortical gene expression identified by microarray analysis: implications for schizophrenia von Kaiser, Sergio, Foltz, Lisa A, George, Carolyn A, Kirkwood, Sandra C, Bemis, Kerry G, Lin, Xi, Gelbert, Lawrence M, Nisenbaum, Laura K

Volltext

Subgroup analyses of the amyloid PET substudies from EMERGE and ENGAGE, phase 3 clinical trials evaluating aducanumab in patients with early Alzheimer’s disease von Rajagovindan, Raj, Chen, Tianle, Wu, Hao, Tian, Ying, Nisenbaum, Laura, Castrillo‐Viguera, Carmen, He, Ping, Haeberlein, Samantha Budd

Volltext

Concordance of CSF biomarkers with amyloid PET at baseline in EMERGE/ENGAGE, phase 3 studies of aducanumab in patients with early Alzheimer’s disease von Rubel, Carrie E., Nisenbaum, Laura, Chen, Tianle, Dent, Gersham, Fraser, Kyle, Graham, Danielle, Harrison, Katie, He, Ping, Racine, Annie M, Rajagovindan, Raj, Beaver, John, Haeberlein, Samantha Budd

Volltext

Investigating the neuroimmunogenic architecture of schizophrenia von Birnbaum, R, Jaffe, A E, Chen, Q, Shin, J H, Kleinman, J E, Hyde, T M, Weinberger, D R

Volltext

Evaluation of common gene expression patterns in the rat nervous system von Kaiser, Sergio, Nisenbaum, Laura K

Volltext